share_log

藥明康德:董事會會議召開日期

WUXI APPTEC: DATE OF BOARD MEETING

Hong Kong Stock Exchange ·  Apr 15 05:07
Summary by Moomoo AI
药明康德宣布將於2024年4月29日(星期一)召開董事會會議,目的是考慮及批准本集團截至2024年3月31日止三個月的第一季業績及其發佈。董事會成員包括執行董事李革博士、陳民章博士、胡正國先生、楊青博士及張朝暉先生;非執行董事童小幪先生及吳亦兵博士;以及獨立非執行董事盧韶華女士、俞衛博士、張新博士、詹智玲女士及馮岱先生。會議的召開將為投資者提供公司最新的財務表現概況。
药明康德宣布將於2024年4月29日(星期一)召開董事會會議,目的是考慮及批准本集團截至2024年3月31日止三個月的第一季業績及其發佈。董事會成員包括執行董事李革博士、陳民章博士、胡正國先生、楊青博士及張朝暉先生;非執行董事童小幪先生及吳亦兵博士;以及獨立非執行董事盧韶華女士、俞衛博士、張新博士、詹智玲女士及馮岱先生。會議的召開將為投資者提供公司最新的財務表現概況。
Ming Kand Pharmaceuticals announces that a Board Meeting will be held on Monday, 29 April 2024 to consider and approve the Group's first quarter results for the three months ended 31 March 2024 and their release. The members of the Board of Directors include the Executive Directors Dr. Li Keung, Dr. Chen Minchang, Mr. Hu Cheng Guo, Dr. Yang Ching and Mr. Zhang Chahui; the Non-Executive Directors Mr. Tou Xiao Hui and Dr. Wu Yibing; and the Independent Non-Executive Directors Ms. Lu Shao-hua, Dr. Yu Wei, Dr. Zhang Xin, Ms. Zhan Chi-ling and Mr. Fung Dai. The meeting will provide investors with an up-to-date overview of the company's financial performance.
Ming Kand Pharmaceuticals announces that a Board Meeting will be held on Monday, 29 April 2024 to consider and approve the Group's first quarter results for the three months ended 31 March 2024 and their release. The members of the Board of Directors include the Executive Directors Dr. Li Keung, Dr. Chen Minchang, Mr. Hu Cheng Guo, Dr. Yang Ching and Mr. Zhang Chahui; the Non-Executive Directors Mr. Tou Xiao Hui and Dr. Wu Yibing; and the Independent Non-Executive Directors Ms. Lu Shao-hua, Dr. Yu Wei, Dr. Zhang Xin, Ms. Zhan Chi-ling and Mr. Fung Dai. The meeting will provide investors with an up-to-date overview of the company's financial performance.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more